Loading...

The European Board of Cardiovascular Perfusion

Optimizing patient management with CytoSorb Hemoperfusion Therapy in Cardiac Surgery - scientific evidence and clinical practice Webinar No. 1

Optimizing patient management with CytoSorb Hemoperfusion Therapy in Cardiac Surgery - scientific evidence and clinical practice

International Experts meeting - 21 Jan 2021.pdf

21 January 2021 – 5pm-6pm CET

Reduce bleeding complications in ticagrelor and rivaroxaban treated patients

undergoing emergency Cardiac Surgery

Chair: Prof. Michael Schmoeckel, Hamburg/Germany

- Why is it relevant?

Prof. Michael Storey, Sheffield/UK

- How bleeding complications and costs can be reduced?

Dr. Stephan Geidel, Hamburg/Germany

- Do we have a novel treatment approach to avoid re-thoracotomies?

Dr. Nikola Bradic, Zagreb/Croatia

- Panel discussion


Share this Post!